Itive antinukle Re Antique Body and Antique AntidsDNA body. She was called to our PM Tal for further examination and treatment in the M March. k rperliche examination on admission to our gap h Capital and ulnar and rheumatoid IGF-1R swan-neck deformities t observed in the fingers. AR changes was due to the presence of morning stiffness, arthritis, radiological Ver And diagnosed a positive test for RF. Disease Activity Score injoints DASerythrocyte ESR erythrocyte sedimentation rate was Steinbrocker classification of these patients had stage IV and Class III. She had no history of butterfly rash, photosensitivity, hair loss, mouth ulcers, or Raynaud’s phenomenon Ph Is. She was diagnosed with SLE coexisting with rheumatoid arthritis Of.
Although the complication of lupus nephritis has been proposed, refused a nephrologist, a kidney biopsy because of Blutpl Ttchen cause thrombocytopenia. Ml at a time. It was first intravenously Linezolid S administered cortico Followed by methylprednisolone, mgday consecutive days by cortico Of oral prednisolone, mgday Fig. urine casts and pericardial effusion disappeared and the platelet count rose moderately, but there are significant immunological lligkeiten reqs. In addition, L appeared Emissions disco Of polyarthralgia and was quickly w During dose reduction of various prednisolonemgday at the time still Rft so IVCY therapyor mgbody began in May. Although the L Emissions disco Disappearances were no other clinical and laboratory parameters determined. Therefore, the TAC was introduced mgday onAugust. IVCY treatment due to adverse effects of alopecia onSeptember stopped.
Polyarthralgia improved slightly after the introduction of the TAC, but their full therapeutic effect was clearly inadequate. Since the minimal concentration of serum TAC was relatively low. ngdL we have tried to hen the dose increased. However, she developed severe performing Ll TAC dose increased, so we were forced to leave their original dose increased Lt Therefore, we decided to introduce a combination therapy with blocking IL onOctober after obtaining the consent of the patient. As some reports have suggested that TNF-inhibitors has the potential to exacerbate SLE have w We additionally the hlten USEFUL treatment with TCZ. Complete relief of symptoms My joints was achieved remission and DAS criteria for initiating therapy TCZ.
It also enhances erh Increase in serum antibody Body immune complex antidsDNA and quickly. Although thrombocytopenia and decreased levels narrows the serum complement from bad to worse with the dosage of prednisolone, they tended to improve. Corticostro Oral was slightly tapered, but the dose of TAC and TCZ has not GE Changed. The Krankheitsaktivit was t completely suppressed by the regime for six months with no complications, including infections. of rheumatoid arthritis and systemic lupus erythematosus has been reported and tested therapies seem to be necessary to treat rheumatoid arthritis erythematosus and systemic lupus. In our case, the corticostro Of, and salazosulfapyridine IVCY ineffective, and it was difficult because of thrombocytopenia MTX derivative lupus erythematosus to use. The patient responds to therapy TAC show partial improvement of symptoms My common, but its immunological events were not controlled Strips. After the start of combination antiretroviral therapy with TCZ, which not only reached a complete remission of rheumatoid arthritis Of,